icr.ac.uk

CLOSED: Enabling Oral Delivery of VHL-based PROTACs Through Formulation and Prodrug Design

Proteolysis-targeting chimeras (PROTACs), particularly those incorporating the von Hippel–Lindau (VHL) E3 ligase ligand, present significant physicochemical challenges due to their large molecular ...